These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34597376)

  • 1. Anticoagulant therapy in patients with congenital FXI deficiency.
    Bravo-Pérez C; Serna MJ; Esteban J; Fernandez-Mellid E; Fontanes-Trabazo E; Lorenzo A; Calviño-Suárez M; Miñano A; Padilla J; Roldán V; Vicente V; Corral J; de la Morena-Barrio ME
    Blood Adv; 2021 Oct; 5(20):4083-4086. PubMed ID: 34597376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China.
    Shao Y; Cao Y; Lu Y; Dai J; Ding Q; Wang X; Xi X; Wang H
    Blood Cells Mol Dis; 2016 May; 58():29-34. PubMed ID: 27067486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XI and coagulation. Factor XI inhibitors - antithrombotic perspectives.
    Vlădăreanu AM; Roşca A
    Rom J Intern Med; 2024 Jun; 62(2):91-100. PubMed ID: 38153875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic analysis of the F11 gene in 14 Turkish patients with factor XI deficiency: identification of novel and recurrent mutations and their inheritance within families.
    Colakoglu S; Bayhan T; Tavil B; Keskin EY; Cakir V; Gümrük F; Çetin M; Aytaç S; Berber E
    Blood Transfus; 2018 Jan; 16(1):105-113. PubMed ID: 27723456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XI promotes hemostasis in factor IX-deficient mice.
    Mohammed BM; Cheng Q; Matafonov A; Monroe DM; Meijers JCM; Gailani D
    J Thromb Haemost; 2018 Oct; 16(10):2044-2049. PubMed ID: 30007049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre.
    Santoro C; Di Mauro R; Baldacci E; De Angelis F; Abbruzzese R; Barone F; Bochicchio RA; Ferrara G; Guarini A; Foà R; Mazzucconi MG
    Haemophilia; 2015 Jul; 21(4):496-501. PubMed ID: 25623511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor 11 single-nucleotide variants in women with heavy menstrual bleeding.
    Wiewel-Verschueren S; Mulder AB; Meijer K; Mulder R
    J Obstet Gynaecol; 2017 Oct; 37(7):912-918. PubMed ID: 28609141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XI inhibition in cardiovascular disease.
    Carlin S; Jakovac M; Budaj A; Eikelboom J
    Pol Arch Intern Med; 2024 Aug; 134(7-8):. PubMed ID: 38984712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.
    Batty P; Honke A; Bowles L; Hart DP; Pasi KJ; Uprichard J; Austin SK
    Haemophilia; 2015 Jul; 21(4):490-5. PubMed ID: 25855341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hemostatic role of factor XI.
    Puy C; Rigg RA; McCarty OJ
    Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynaecological and obstetrical bleeding in Caucasian women with congenital factor XI deficiency: Results from a twenty-year, retrospective, observational study.
    Bravo-Perez C; Ródenas T; Esteban J; de la Morena-Barrio ME; Salloum-Asfar S; de la Morena-Barrio B; Miñano A; Vicente V; Corral J
    Med Clin (Barc); 2019 Nov; 153(10):373-379. PubMed ID: 30926156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XI-deficient mice exhibit increased bleeding after injury to the saphenous vein.
    Ay C; Hisada Y; Cooley BC; Mackman N
    J Thromb Haemost; 2017 Sep; 15(9):1829-1833. PubMed ID: 28677246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proposal for managing bleeding in patients on therapeutic factor XI(a) inhibitors.
    Salomon O; Gailani D
    J Thromb Haemost; 2022 Jan; 20(1):32-38. PubMed ID: 34735741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of factor XI deficiency in Southeast China: four recurrent variants can explain most of the deficiencies.
    Zhang K; Qin L; Xu F; Ye L; Wen M; Pan J; Yang L; Wang M; Xie H
    Orphanet J Rare Dis; 2024 Jun; 19(1):224. PubMed ID: 38835089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting factor XI and factor XIa to prevent thrombosis.
    Gailani D; Gruber A
    Blood; 2024 Apr; 143(15):1465-1475. PubMed ID: 38142404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of hereditary factor XI deficiency in Taiwanese patients: identification of three novel and two common mutations.
    Lin HY; Lin CY; Hung MH; Kuo SF; Lin JS; Shen MC
    Int J Hematol; 2020 Aug; 112(2):169-175. PubMed ID: 32333264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of factor XI (FXI) concentrate use in patients with FXI deficiency: a single-centre experience of 19 years.
    Ling G; Kagdi H; Subel B; Chowdary P; Gomez K
    Haemophilia; 2016 May; 22(3):411-8. PubMed ID: 26663472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency.
    Pike GN; Cumming AM; Hay CR; Sempasa B; Sutherland M; Thachil J; Burthem J; Bolton-Maggs PH
    Haemophilia; 2016 May; 22(3):403-10. PubMed ID: 26558335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital factor XI deficiency: an update.
    Duga S; Salomon O
    Semin Thromb Hemost; 2013 Sep; 39(6):621-31. PubMed ID: 23929304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: Results from the Yecla study.
    Esteban J; de la Morena-Barrio ME; Salloum-Asfar S; Padilla J; Miñano A; Roldán V; Soria JM; Vidal F; Corral J; Vicente V
    Haemophilia; 2017 Nov; 23(6):e488-e496. PubMed ID: 28960694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.